|
Seminar: Engineering Next-Generation of Viral Vectors for Gene Therapy
|
 To View detail, click here
|
To View detail, click here
|
To View detail, click here
|
Seminar: Cardiovascular Sequelae of Long COVID-19 in Adults
|
Seminar: EM based Epitope Mapping and Vaccine Development
|
To View detail, click here
|
To View detail, click here
|
Timely booster vaccination reduces omicron breakthrough infections and COVID-19 severity
|
HKUMed discovers a novel immunotherapeutic target against hepatocellular carcinoma first time in the world
|
To View detail, click here
|
To View detail, click here
|
To View detail, click here
|
To View detail, click here
|
To View detail, click here
|
2021 Chinese Scientists with Cell Press: Most Picked Award
|
To View detail, click here
|
To View detail, click here
|
To View detail, click here
|
HKUMed found that robust SARS-CoV-2 infection in nasal turbinate underlies incomplete protection by systemic antibody or vaccine
|
To View detail, click here
|
.jpg)
To View detail, click here
|
Smart Talk | Experts clarify: Is it safe to take COVID-19 vaccines?
|
Treatment as Prevention: Reducing Cases of HIV/AIDS
|
To View detail, click here
|
To View detail, click here
|
To View detail, click here
|
HKU AIDS Institute Invents Universal
Antibody Drug for HIV-1 Prevention
and Immunotherapy
26 Apr 2018 |
HKU AIDS Institute joins the world effort as a partner of CTVD in the search of an effective TB vaccine. CTVD represents "The Collaboration for TB Vaccine Discovery".
|
|